Performance Boosted by NexTech’s AR e-Commerce Division New York, NY – Toronto, ON – December 3rd, 2019 – NexTech AR Solutions (the “Company” or “NexTech”) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), the industry leader in augmented […]
VANCOUVER, Washington, Dec 03, 2019 — First metastatic triple-negative breast cancer patient showed no detectable circulating tumor cells (CTC) or putative metastatic tumor cells (EMTs) in the peripheral blood. Further, a significant reduction in CCR5 […]
Magento 2.0 AR integration will drive more online sales from AR for eCommerce NEW YORK and TORONTO, Nov 28, 2019 — NexTech AR Solutions (NexTech) (otcqb:NEXCF) (NTAR)(N29), the leader in augmented reality for eCommerce, learning […]
Using CaptureAR NexTech enters the $1.5 trillion global clothing and apparel marketplace NEW YORK and TORONTO, Nov 26, 2019 — NexTech AR Solutions (NexTech) (otcqb:NEXCF) (NTAR)(N29), the leader in augmented reality (AR) for eCommerce and […]
Collaboration will Target a Therapeutic Approach for Treating Asthma and Allergic Diseases NEW YORK, Nov. 26, 2019– Hoth Therapeutics, Inc. (NASDAQ: HOTH), (“HOTH” or the “Company”), a biopharmaceutical company focused on developing new generation therapies for dermatological […]
New preclinical data using a humanized mouse model confirms and expands on the potential use of leronlimab in treating this inflammatory syndrome, a common precursor to NASH VANCOUVER, Washington, Nov 21, 2019 — CytoDyn Inc. […]
Company accelerates with sign up of new AR ecomm customers NEW YORK and TORONTO, Nov 21, 2019 — NexTech AR Solutions (NexTech) (otcqb:NEXCF) (NTAR)(N29), the leader in augmented reality for e-commerce and AR learning applications, […]
TARRYTOWN, NY, Nov. 20, 2019– Nightfood, Inc. (otcqb:NGTF), the award-winning ice cream company addressing America’s $50 billion-dollar nighttime snacking problem, yesterday received confirmation that sleep-friendly Nightfood ice cream will soon be made available in a […]
CytoDyn will file for expanded access IND for patients with pancreatic, prostate, lung, breast, liver and melanoma cancers VANCOUVER, Washington, Nov 19, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology […]
One-of-a-kind, transformative technology for retailers combines messaging and AR experiences NEW YORK and TORONTO, Nov 19, 2019– NEW YORK and TORONTO, Nov. 19, 2019 — NexTech AR Solutions (the “Company” or “NexTech”) (otcqb:NEXCF) (NTAR)(N29), the […]
NEW YORK, Nov. 18, 2019 — Hoth Therapeutics, Inc. (NASDAQ: HOTH) (“HOTH” or the “Company”), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, […]
Augmented reality (AR) is set to change the way organizations compete in the transportation industry NEW YORK and TORONTO, Nov 14, 2019 — November 14, 2019 – NexTech AR Solutions (the “Company” or “NexTech”) (otcqb:NEXCF) […]
NEW YORK, Nov. 14, 2019 — Hoth Therapeutics, Inc. (NASDAQ: HOTH) (“HOTH” or the “Company”), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, […]
VANCOUVER, Washington, Nov. 12, 2019 – CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today it has […]
Breakthrough Therapy designation filing possible if more patients show similar positive results VANCOUVER, Washington, Nov. 11, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
